Abzena PLC Fundamentals Datasheet and Stock Analysis

Profile

Abzena PLC Company Logo
Abzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups. It offers immunogenicity assessment, which includes EpiScreen, iTope and T Cell Epitope Database (TCED); antibody drug conjugates, which includes ThioBridge linkers; antibody, which includes Composite Human Antibodies and Composite Proteins; optimization of pharmacokinetics, which includes TheraPEG, HiPEG conjugates PEG to poly-histidine motifs and CyPEG, and PolyPEG; cell line development, which includes Composite Human Antibody; process development, Good manufacturing practices (GMP) manufacturing, and small molecules. The Company's Abzena inside includes Composite Human Antibodies and ThioBridge Antibody Drug Conjugates (ADCs).

  • Current Price:
     19.50p
  • Industry:
     Health Care
  • Sector:
     Health Care
  • ISIN:
     GB00BN65QN46
  • Market Sector:
     AIM
  • Main Indices:
     FTSE AIM
  • Country of register:
     Great Britain
  • Currency:
     N/A
  • Shares in Issue:
     214m
  • Market Cap:
     £0m
  • Date Listed:
     10/07/2014
Operation Breakdown
Geographical - by origin (turnover)
Product (turnover)

Loading...

Activity Data Not Available

Company Information

CEO: John Burt  CFO: Julian Smith  Chairman: Ken Cunningham  Non-Executive Director: Peter Grant, Anthony Brampton, Nigel Pitchford Lotta Ljungqvist  Chief Business Officer: Sven Lee  

  • Registrars:
     
  • Address:
     Babraham Research Campus, Babraham, Cambridge, United Kingdom
  • Phone:
     
  • Website:
     
Analysis
Composite Ranking: 52
Historic EPS Ranking: 52
Forecast EPS Ranking: 19
Price Relative Strength: 8
Industry Strength: E
SMR Ranking: A
ROCE Ranking: F
Accumulation/Dist: 
Mkt Accumulation/Dist: C
Unbroken Annual EPS: E
Unbroken Interim EPS: E
PEG Current Ranking: A
PEG Forecast Ranking: A
PE Current Ranking: A
PE Forecast Ranking: A
Margin Current Ranking: H
Margin Forecast Ranking: G
Chart
Add Indicator




loading




Takes the average of data over a period of time, and migrates the period across the data series one data point at a time. This formula smooths a data series and makes analysing volatile data easier.
Fundamentals
20142015201620172018E2019E2020E
Day/Month31/331/331/331/331/331/331/3
Revenue£m5.265.679.8518.65£m21.7829.2138.63
Operating Profit/(loss)£m(4.12)(5.30)10.90(9.74)£m0.000.000.00
Profit Before Tax£m(4.10)(5.22)(10.66)(9.46)£m(15.07)(12.10)(7.58)
Profit After Tax£m(3.55)(4.72)(9.70)(9.12)£m0.000.000.00
Profit After Tax (from discontinued operations)£m0.000.000.000.00£m0.000.000.00
Overall Profit for the Period£m(3.55)(4.72)(9.70)(9.12)£m0.000.000.00
EPS Growth%0.000.000.000.00%0.000.000.00
Earnings Per Sharep(253.00)(7.00)(9.00)(7.00)p(7.57)(6.68)(3.32)
Op. Cash Flow P/Sp0.000.000.000.00£0.000.000.00
Cash Flow P/S Grth%0.000.000.000.00%0.000.000.00
Net Cash Flow P/Sp0.000.000.000.00£0.000.000.00
Capital Exp P/S£0.000.000.000.00£0.000.000.00
Tax Rate%0.000.000.000.00%0.000.000.00
P/E Ratiox0.000.000.000.00x0.000.000.00
P/E Growth£0.000.000.000.00£0.000.000.00
Turnover Per Share£0.000.000.000.00£0.000.000.00
Pre-Tax Profit / Share£0.000.000.000.00£0.000.000.00
Operating Margin%(78.39)(93.47)110.66(52.23)%0.000.000.00
ROCE%(77.73)(26.02)(53.54)(74.37)%0.000.000.00
ROE%0.000.000.000.00%0.000.000.00
Mkt Cap£m0.00179.95107.1180.33£m0.000.000.00
Dividend Per Sharep0.000.000.000.00p0.000.000.00
DPS Growth%0.000.000.000.00%0.000.000.00
Dividend Yield%0.000.000.000.00%0.000.000.00
Dividend Coverx0.000.000.000.00x0.000.000.00
Shareholder Funds£m13.5327.8541.0635.93£m0.000.000.00
Net Borrowings£m(2.76)(15.80)(13.72)(4.13)£m0.000.000.00
Net Assets£m13.5327.8541.0635.93£m0.000.000.00
Net Assets P/S£0.000.000.000.00£0.000.000.00
Financials
Latest Forecast
Div Yield0.0%0.0%
Div Cover0.0%0.0%
Op Margin-52.2%-41.4%
ROCE0.0%
Director Deals
Traded Action Notifier Price Amount Value
10-Apr-17Transfer ToPeter Grant33.00p 25,000£8,250
16-Aug-16Exercise of optionAnker Lundemose0.02p 75,000£15
27-Jun-16Transfer ToJohn Burt41.00p 98,000£40,180
  Rows per page
Shareholders
214m    Major: 76%    Director: 1%
Notifier Holding Value
John Burt2,120,262413,451.09
Julian Smith262,08451,106.38
Peter Grant58,30311,369.08
  Rows per page
Gearing & Cover
Broker Opinion
Date Broker Name Rec Price Old Price Target New Price Target Broker Change
08-Jun-15N 1 SingerBuy86.00p0.00p0.00pReiteration
  Rows per page
Notes

This functionality requires you to login

Click here to login
Or register for a new account